S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 94.9 TWD -1.15% Market Closed
Market Cap: 11.3B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

SCI Pharmtech Inc
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SCI Pharmtech Inc
Long-Term Debt Peer Comparison

Comparables:
Y
3705
4746
1789
1795
1720

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Long-Term Debt
NT$870.4m
CAGR 3-Years
768%
CAGR 5-Years
265%
CAGR 10-Years
4%
Y
YungShin Global Holding Corp
TWSE:3705
Long-Term Debt
NT$327m
CAGR 3-Years
-23%
CAGR 5-Years
-5%
CAGR 10-Years
8%
Formosa Laboratories Inc
TWSE:4746
Long-Term Debt
NT$2.4B
CAGR 3-Years
4%
CAGR 5-Years
-2%
CAGR 10-Years
13%
ScinoPharm Taiwan Ltd
TWSE:1789
Long-Term Debt
NT$624.9m
CAGR 3-Years
5%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Lotus Pharmaceutical Co Ltd
TWSE:1795
Long-Term Debt
NT$9.6B
CAGR 3-Years
16%
CAGR 5-Years
25%
CAGR 10-Years
87%
Standard Chem & Pharm Co Ltd
TWSE:1720
Long-Term Debt
NT$408.9m
CAGR 3-Years
18%
CAGR 5-Years
11%
CAGR 10-Years
15%

See Also

What is SCI Pharmtech Inc's Long-Term Debt?
Long-Term Debt
870.4m TWD

Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Long-Term Debt amounts to 870.4m TWD.

What is SCI Pharmtech Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
4%

Over the last year, the Long-Term Debt growth was 47%. The average annual Long-Term Debt growth rates for SCI Pharmtech Inc have been 768% over the past three years , 265% over the past five years , and 4% over the past ten years .

Back to Top